Reading NATR? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track NATR free→Reading NATR? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track NATR free→QuarterlyIQ Insights · NATR
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Resignation of Chief Financial Officer On May 8, 2026, L. Shane Jones notified Nature’s Sunshine Products, Inc. (the “Company”) that he is resigning as the Company’s Chief Financial Officer effective June 5, 2026. As the Company’s Chief Financial Officer, Mr. Jones also served as the Company’s Principal Financial Officer. Mr. Jones’ resignation was…
and the exhibit hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such filing. The press release furnished herewith makes reference to non-GAAP financial information, which the Company's management believes assis…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On May 6, 2026, Nature’s Sunshine Products, Inc. (the “Company”) held its 2026 Annual Meeting of Shareholders (the “Annual Meeting”) and the shareholders of the Company approved the adoption of the 2026 Stock Incentive Plan (the “Plan”). With shareholder approval obtained, the Plan is effective as of May 6, 2026. Subject to adjustment in certain ci…
and the exhibit hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such filing. The press release furnished herewith makes reference to non-GAAP financial information, which the Company's management believes assis…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Compensatory Arrangements of Certain Officers On February 24, 2026, the Compensation Committee of the Company approved an increase to the base salary of the Company’s Chief Financial Officer, Mr. L. Shane Jones, from $478,400 to $492,752 which increase is effective March 8, 2026. On February 24, 2026, the Compensation Committee of the Company appro…
and the exhibit hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such filing. The press release furnished herewith makes reference to non-GAAP financial information, which the Company's management believes assis…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On May 28, 2025, Nature’s Sunshine Products, Inc. (the “Company”) announced that the Board of Directors (the “Board”) would be conducting a search for a new President and Chief Executive Officer of the Company in light of Terrence O. Moorehead’s notice to the Board that he has decided to step down as President, Chief Executive Office and as a membe…
and the exhibit hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such filing. The press release furnished herewith makes reference to non-GAAP financial information, which the Company's management believes assis…
ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT. As previously disclosed, on August 25, 2014, Nature’s Sunshine Products, Inc. (the “Company”), completed a transaction with Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma”), which created two joint ventures each owned 80% by the Company and 20% by Fosun Industrial Co., Ltd., (“Fosun Industrial”). a wholly owned subsidiary of Fosun Pharma. The joint ventures, known as Nature’s Sunshine Hong Kong Limited (the “Hong Kong Joint Venture”)…
ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT. On June 25, 2025, Nature’s Sunshine Products, Inc., a Utah corporation (the “Company”), entered into an underwriting agreement (the “Underwriting Agreement”) with D.A. Davidson & Co. as representative of the several underwriters listed in Schedule A thereto (the “Underwriters”), and Fosun Pharma USA, Inc. (the “Selling Stockholder”), relating to an underwritten secondary public offering of 2,854,607 shares of common stock of the Company, no par valu…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On May 28, 2025, Terrence O. Moorehead, the President, Chief Executive Officer and member of the Board of Directors (the “Board”) of Nature’s Sunshine Products, Inc. (the “Company”) notified the Board that he has decided to step down as an officer and resign as a director of the Company, effective upon the appointment by the Company of a successor…
and the exhibit hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such filing. The press release furnished herewith makes reference to non-GAAP financial information, which the Company's management believes assis…
and the exhibit hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such filing. The press release furnished herewith makes reference to non-GAAP financial information, which the Company's management believes assis…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Compensatory Arrangements of Certain Officers On March 4, 2025, the Compensation Committee of the Company approved an increase to the base salary of the Company’s Chief Financial Officer, Mr. L. Shane Jones, from $460,000 to $478,400 which increase is effective March 4, 2025. On March 4, 2025, the Compensation Committee of the Company approved an i…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On January 30, 2025, the Company’s Board of Directors appointed Ms. Katie A. May to its Board of Directors. Ms. May has been appointed to serve as a director until the next shareholders’ meeting at which directors are elected. Ms. May will serve on the Compensation and Governance Committees of the Board. Ms. May, 58, was previously the founder and…
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.